Chronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you're ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with ...

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

If your allergy symptoms—sneezing, itchy eyes, or nasal congestion—continue to be a problem even after using medication, you ...

Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

Verona Pharma’s flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...

While smoke is bad for everyone, children, older adults, pregnant people, people with heart and lung disease, and people who ...

As of late Friday morning the air quality levels around Montezuma County have reached moderate levels, according to the U.S.

Dietary approaches are shaping up as a key aspect of chronic obstructive pulmonary disease (COPD) management.

Upstream Bio has dosed the first subject in the Phase II trial of verekitug in individuals with chronic obstructive pulmonary disease (COPD).

Broadens global development program for verekitug into third indication, strengthening pipeline across severe respiratory diseases including chronic rhinosinusitis with nasal polyps (CRSwNP), severe ...